Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Mohit Kaushal

Director at Oncology Institute, Inc. (STLN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $335K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 16SEC STLNOncology Institute, Inc. Sell Plan 57,286211,016 held (−21%) $3.50 $201K +83.7%
Apr 16SEC STLNOncology Institute, Inc. Sell Plan 38,433172,583 held (−18%) $3.50 $135K +83.7%
  • Sell

    Director Mohit Kaushal sold $201K of STLN at $3.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Mohit Kaushal sold $135K of STLN at $3.50 — pre-scheduled 10b5-1 plan sale.